Diabetes & Metabolism Journal

Indexed in SCIE, Medline

- The incidence rate of CKD was over 4%/year among our Iranian diabetic population.
- Older age, history of CVD, and lower levels of eGFR were significant risk factors.
- Using glucose-lowering drugs and hypertension increased risk in CKD-EPI analysis.
- Female sex and FPG level ≥10 mmol/L were also independent risk factors in MDRD.
- CKD-EPI had higher discriminatory ability for prediction of CKD than MDRD.

-Nonalcoholic fatty liver disease (NAFLD) and albuminuria are associated with the aggravation of coexisting metabolic diseases.
-Of total 100 patients with both type 2 diabetes (T2DM) and NAFLD, but without chronic kidney disease were recruited.
-T2DM patients with significant hepatic steatosis had a higher prevalence of albuminuria.
-Albuminuria showed a correlation with hepatic fatty burden, and was independently associated with significant hepatic steatosis.

-Most guidelines advocated lower official BP targets (-Inconsistency was observed among guidelines on the official BP thresholds for pharmacologic therapy in diabetes.
-Hardly any of the guidelines provided relevant recommendations on the lower limit of official BP targets in diabetes.
-Current guidelines lacked recommendations on ABPM/HBPM management in diabetes.